PortfoliosLab logo
TRAK vs. TRML
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TRAK and TRML is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

TRAK vs. TRML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Park City Group Inc (TRAK) and Tourmaline Bio Inc. (TRML). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%NovemberDecember2025FebruaryMarchApril
338.90%
-76.60%
TRAK
TRML

Key characteristics

Sharpe Ratio

TRAK:

1.00

TRML:

0.18

Sortino Ratio

TRAK:

1.54

TRML:

0.75

Omega Ratio

TRAK:

1.19

TRML:

1.08

Calmar Ratio

TRAK:

1.38

TRML:

0.14

Martin Ratio

TRAK:

3.50

TRML:

0.42

Ulcer Index

TRAK:

10.92%

TRML:

28.55%

Daily Std Dev

TRAK:

38.27%

TRML:

66.07%

Max Drawdown

TRAK:

-96.87%

TRML:

-94.97%

Current Drawdown

TRAK:

-13.59%

TRML:

-79.57%

Fundamentals

Market Cap

TRAK:

$390.10M

TRML:

$444.86M

EPS

TRAK:

$0.32

TRML:

-$2.89

PS Ratio

TRAK:

18.40

TRML:

0.00

PB Ratio

TRAK:

8.14

TRML:

1.45

Total Revenue (TTM)

TRAK:

$16.11M

TRML:

$40.00K

Gross Profit (TTM)

TRAK:

$13.41M

TRML:

$10.00K

EBITDA (TTM)

TRAK:

$6.15M

TRML:

-$72.20M

Returns By Period

In the year-to-date period, TRAK achieves a -3.44% return, which is significantly higher than TRML's -16.72% return.


TRAK

YTD

-3.44%

1M

3.58%

6M

11.10%

1Y

32.04%

5Y*

37.87%

10Y*

6.52%

TRML

YTD

-16.72%

1M

0.96%

6M

-36.48%

1Y

7.72%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TRAK vs. TRML — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRAK
The Risk-Adjusted Performance Rank of TRAK is 8282
Overall Rank
The Sharpe Ratio Rank of TRAK is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of TRAK is 7979
Sortino Ratio Rank
The Omega Ratio Rank of TRAK is 7676
Omega Ratio Rank
The Calmar Ratio Rank of TRAK is 8989
Calmar Ratio Rank
The Martin Ratio Rank of TRAK is 8282
Martin Ratio Rank

TRML
The Risk-Adjusted Performance Rank of TRML is 5959
Overall Rank
The Sharpe Ratio Rank of TRML is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of TRML is 6060
Sortino Ratio Rank
The Omega Ratio Rank of TRML is 5656
Omega Ratio Rank
The Calmar Ratio Rank of TRML is 6060
Calmar Ratio Rank
The Martin Ratio Rank of TRML is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TRAK vs. TRML - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Park City Group Inc (TRAK) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for TRAK, currently valued at 1.00, compared to the broader market-2.00-1.000.001.002.003.00
TRAK: 1.00
TRML: 0.18
The chart of Sortino ratio for TRAK, currently valued at 1.54, compared to the broader market-6.00-4.00-2.000.002.004.00
TRAK: 1.54
TRML: 0.75
The chart of Omega ratio for TRAK, currently valued at 1.19, compared to the broader market0.501.001.502.00
TRAK: 1.19
TRML: 1.08
The chart of Calmar ratio for TRAK, currently valued at 1.38, compared to the broader market0.001.002.003.004.005.00
TRAK: 1.38
TRML: 0.14
The chart of Martin ratio for TRAK, currently valued at 3.50, compared to the broader market-5.000.005.0010.0015.0020.00
TRAK: 3.50
TRML: 0.42

The current TRAK Sharpe Ratio is 1.00, which is higher than the TRML Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of TRAK and TRML, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.00
0.18
TRAK
TRML

Dividends

TRAK vs. TRML - Dividend Comparison

TRAK's dividend yield for the trailing twelve months is around 0.32%, while TRML has not paid dividends to shareholders.


TTM202420232022
TRAK
Park City Group Inc
0.32%0.31%0.76%0.30%
TRML
Tourmaline Bio Inc.
0.00%0.00%57.75%0.00%

Drawdowns

TRAK vs. TRML - Drawdown Comparison

The maximum TRAK drawdown since its inception was -96.87%, roughly equal to the maximum TRML drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for TRAK and TRML. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-13.59%
-79.57%
TRAK
TRML

Volatility

TRAK vs. TRML - Volatility Comparison

The current volatility for Park City Group Inc (TRAK) is 12.88%, while Tourmaline Bio Inc. (TRML) has a volatility of 23.05%. This indicates that TRAK experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
12.88%
23.05%
TRAK
TRML

Financials

TRAK vs. TRML - Financials Comparison

This section allows you to compare key financial metrics between Park City Group Inc and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items